Cidara Therapeutics Inc (FRA:20D0) Stock News, Headlines & Updates
Cidara Therapeutics Inc Stock News from GuruFocus
- 1
- 2
Jul 09, 2025
Cidara Therapeutics (CDTX) Target Price Raised by Guggenheim | CDTX Stock News
GuruFocus News • 6:16am
COMMODORE CAPITAL LP Acquires 1,175,000 Shares in Cidara Therapeutics Inc
GuruFocus News • 7:33pm
Jul 01, 2025
Cidara Therapeutics Inc (CDTX) Announces Stock Option Awards to New Employees | CDTX stock news
GuruFocus News • 6:04pm
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
GlobeNewswire • 5:00pm
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) | CDTX Stock News
GuruFocus News • 4:16pm
Cidara Therapeutics Inc (CDTX) Announces Stock Option Awards to New Employees | CDTX stock news
GuruFocus News • 4:12pm
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Marketwired • 4:00pm
Jun 30, 2025
Cidara Therapeutics (CDTX) Rating and Price Target Maintained by JMP Securities | CDTX Stock News
GuruFocus News • 8:32am
Cidara Therapeutics Inc (CDTX) Joins Russell 2000 and Russell 3000 Indexes | CDTX stock news
GuruFocus News • 7:02am
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes
Marketwired • 7:00am
Jun 26, 2025
Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
GlobeNewswire • 5:00pm
Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
Marketwired • 5:00pm
Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares | CDTX Stock News
GuruFocus News • 4:30pm
Jun 25, 2025
Cidara Therapeutics (CDTX) Prices Upsized Public Offering at $44 Per Share
GuruFocus News • 3:57am
Cidara Therapeutics (CDTX) Bolsters Financing with Upsized $350M Offering | CDTX Stock News
GuruFocus News • 8:15pm
Cidara Announces Pricing of Upsized Public Offering of Common Stock
Marketwired • 8:00pm
Cidara Announces Pricing of Upsized Public Offering of Common Stock | CDTX Stock News
GuruFocus News • 7:15pm
Jun 24, 2025
Cidara Therapeutics (CDTX) Price Target Raised by RBC Capital | CDTX Stock News
GuruFocus News • 10:00am
Cidara Therapeutics (CDTX) Receives Raised Price Target from Guggenheim | CDTX Stock News
GuruFocus News • 8:00am
Cidara Therapeutics (CDTX) Receives a Price Target Boost | CDTX Stock News
GuruFocus News • 7:02am
Cidara Therapeutics (CDTX) Target Price Boosted by RBC Capital | CDTX Stock News
GuruFocus News • 6:53am
Jun 23, 2025
Cidara Announces Proposed Public Offering of Common Stock
Marketwired • 4:00pm
Cidara Therapeutics (CDTX) Announces $250M Public Offering
GuruFocus News • 3:57pm
Cidara Therapeutics (CDTX) to Launch $250M Public Offering | CDTX Stock News
GuruFocus News • 3:49pm
Cidara Announces Proposed Public Offering of Common Stock | CDTX Stock News
GuruFocus News • 3:32pm
Cidara Therapeutics (CDTX) Surges 110% on Promising Phase 2 Flu Treatment Results
GuruFocus News • 2:58pm
Cidara Therapeutics (CDTX) Price Target Boosted Following Positive Trial Results | CDTX Stock News
GuruFocus News • 12:53pm
Cidara Therapeutics (CDTX) Sees Price Target Raised and Positive Drug Trial Results | CDTX Stock News
GuruFocus News • 12:47pm
Cidara Therapeutics (CDTX) Reveals Promising Phase 2b Trial Results for Influenza Prevention | CDTX Stock News
GuruFocus News • 12:38pm
Cidara Therapeutics (CDTX) Receives Strong Buy Rating from WBB Securities | CDTX Stock News
GuruFocus News • 11:00am
Needham Raises Price Target for CDTX, Maintains "Buy" Rating | CDTX Stock News
GuruFocus News • 10:32am
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza | CDTX Stock News
GuruFocus News • 6:21am
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza
Marketwired • 6:00am
Jun 18, 2025
Cidara Therapeutics (CDTX) Receives Buy Rating from HC Wainwright & Co. | CDTX Stock News
GuruFocus News • 7:31am
H.C. Wainwright Initiates Coverage on Cidara Therapeutics (CDTX) with Strong Outlook | CDTX Stock News
GuruFocus News • 5:31am
Jun 10, 2025
Cidara Therapeutics (CDTX) Reiterates Overweight Rating by Cantor Fitzgerald | CDTX Stock News
GuruFocus News • 10:00am
Jun 04, 2025
Insider Buying: Chrysa Mineo Acquires Shares of Cidara Therapeutics Inc (CDTX)
GuruFocus News • 5:01pm
Cidara Therapeutics (CDTX) Price Target Raised by Needham | CDTX Stock News
GuruFocus News • 6:00am
Jun 02, 2025
Cidara Therapeutics (CDTX) Maintains Market Outperform Rating | CDTX Stock News
GuruFocus News • 11:01am
May 27, 2025
JMP Securities Reiterates Market Outperform Rating for Cidara Therapeutics (CDTX) | CDTX Stock News
GuruFocus News • 8:31am
- 1
- 2
Show
Entries
Headlines
Total 0- 1
No recent news